However, our group has reported that low EVI1 expression was an independent adverse prognostic factor for relapse-free survival (RFS) and overall survival (OS) in pediatric B-ALL patients (18). This evidence concerns the gene RUNX1 and precursor B-cell acute lymphoblastic leukemia.